Recent Updates
Recently added Catalysts
RDY Positive Sentiment Score: 85/100

Dr. Reddy's Laboratories Ltd . 8-2-337, Road No. 3, Banjara Hills Hyderabad - 500 034, Telangana, India CIN: L85195TG1984PLC004507 Tel: + 91 40 4900 2900 Fax: + 91 40 4900 2999 Email: mail@drreddys.com Web: www.drreddys.

Friday, November 14, 2025 1 min read
Key Takeaway: Dr. Reddy's Laboratories announced that the USFDA completed a GMP inspection of its API facility in Srikakulam, Andhra Pradesh, with zero observations. The inspection took place from November 10 to November 14, 2025. This outcome signifies that the facility meets the necessary regulatory standards, reinforcing Dr. Reddy's commitment to quality in manufacturing.

Market Sentiment Analysis

POSITIVE FACTORS

  • USFDA inspection concluded with zero observations, indicating compliance
  • Successful GMP inspection reflects high-quality standards
  • Enhancement of Dr. Reddy's reputation in regulatory compliance

Full Press Release Details

National Stock Exchange of India Ltd. (Scrip Code: DRREDDY)
BSE Limited (Scrip Code: 500124)
New York Stock Exchange Inc. (Stock Code: RDY)
NSE IFSC Ltd. (Stock Code: DRREDDY)
Ref: Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
This is to inform you that the United States Food & Drug Administration (USFDA) today completed a GMP inspection at our API facility (CTO-SEZ) in Srikakulam, Andhra Pradesh. The inspection, carried out between 10th November and 14th November, 2025, has been concluded with zero observations.
This is for your information and record.
For Dr. Reddy's Laboratories Limited
Company Secretary, Compliance Officer & Head-CSR

Frequently Asked Questions

What is the scrip code for Dr. Reddy's on the National Stock Exchange?

The scrip code for Dr. Reddy's on the National Stock Exchange is DRREDDY.

What were the dates of the USFDA GMP inspection?

The USFDA GMP inspection took place from November 10 to November 14, 2025.

What was the outcome of the USFDA inspection at Dr. Reddy's facility?

The USFDA inspection at Dr. Reddy's facility concluded with zero observations.

Which regulatory body conducted the inspection at the Srikakulam facility?

The inspection at the Srikakulam facility was conducted by the USFDA.

Tags: RDY Viatris Investor Conferences Healthcare Dr. Reddy's USFDA GMP inspection Srikakulam API facility
Last updated: Nov 14, 2025